The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cholera Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global Cholera Vaccines market size is expected to reach US$ 153.8 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Cholera Vaccines in various end use industries. The expanding demands from the Oral and Others, are propelling Cholera Vaccines market. Dukoral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Shanchol segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cholera Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cholera Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cholera Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cholera Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cholera Vaccines covered in this report include Shantha Biotechnics Private Limited, PaxVax, Inc., Valneva SE, Merck and Co., Inc., GlaxoSmithKline plc (GSK), Astellas Pharma, Inc., Pfizer, Inc., Emergent BioSolutions, Inc. and Mitsubishi Tanabe Pharma Corporation, etc.
The global Cholera Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Global Cholera Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cholera Vaccines market, Segment by Type:
Dukoral
Shanchol
Vaxchora
Others
Global Cholera Vaccines market, by Application
Oral
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cholera Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
The global Cholera Vaccines market size is expected to reach US$ 153.8 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Cholera Vaccines in various end use industries. The expanding demands from the Oral and Others, are propelling Cholera Vaccines market. Dukoral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Shanchol segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cholera Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cholera Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cholera Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cholera Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cholera Vaccines covered in this report include Shantha Biotechnics Private Limited, PaxVax, Inc., Valneva SE, Merck and Co., Inc., GlaxoSmithKline plc (GSK), Astellas Pharma, Inc., Pfizer, Inc., Emergent BioSolutions, Inc. and Mitsubishi Tanabe Pharma Corporation, etc.
The global Cholera Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Global Cholera Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cholera Vaccines market, Segment by Type:
Dukoral
Shanchol
Vaxchora
Others
Global Cholera Vaccines market, by Application
Oral
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cholera Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cholera Vaccines
1.1 Cholera Vaccines Market Overview
1.1.1 Cholera Vaccines Product Scope
1.1.2 Cholera Vaccines Market Status and Outlook
1.2 Global Cholera Vaccines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cholera Vaccines Market Size by Region (2018-2029)
1.4 Global Cholera Vaccines Historic Market Size by Region (2018-2023)
1.5 Global Cholera Vaccines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cholera Vaccines Market Size (2018-2029)
1.6.1 North America Cholera Vaccines Market Size (2018-2029)
1.6.2 Europe Cholera Vaccines Market Size (2018-2029)
1.6.3 Asia-Pacific Cholera Vaccines Market Size (2018-2029)
1.6.4 Latin America Cholera Vaccines Market Size (2018-2029)
1.6.5 Middle East & Africa Cholera Vaccines Market Size (2018-2029)
2 Cholera Vaccines Market by Type
2.1 Introduction
2.1.1 Dukoral
2.1.2 Shanchol
2.1.3 Vaxchora
2.1.4 Others
2.2 Global Cholera Vaccines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cholera Vaccines Historic Market Size by Type (2018-2023)
2.2.2 Global Cholera Vaccines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cholera Vaccines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cholera Vaccines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cholera Vaccines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cholera Vaccines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cholera Vaccines Revenue Breakdown by Type (2018-2029)
3 Cholera Vaccines Market Overview by Application
3.1 Introduction
3.1.1 Oral
3.1.2 Others
3.2 Global Cholera Vaccines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cholera Vaccines Historic Market Size by Application (2018-2023)
3.2.2 Global Cholera Vaccines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cholera Vaccines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cholera Vaccines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cholera Vaccines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cholera Vaccines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cholera Vaccines Revenue Breakdown by Application (2018-2029)
4 Cholera Vaccines Competition Analysis by Players
4.1 Global Cholera Vaccines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2022)
4.3 Date of Key Players Enter into Cholera Vaccines Market
4.4 Global Top Players Cholera Vaccines Headquarters and Area Served
4.5 Key Players Cholera Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 Cholera Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Shantha Biotechnics Private Limited
5.1.1 Shantha Biotechnics Private Limited Profile
5.1.2 Shantha Biotechnics Private Limited Main Business
5.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Products, Services and Solutions
5.1.4 Shantha Biotechnics Private Limited Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.1.5 Shantha Biotechnics Private Limited Recent Developments
5.2 PaxVax, Inc.
5.2.1 PaxVax, Inc. Profile
5.2.2 PaxVax, Inc. Main Business
5.2.3 PaxVax, Inc. Cholera Vaccines Products, Services and Solutions
5.2.4 PaxVax, Inc. Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.2.5 PaxVax, Inc. Recent Developments
5.3 Valneva SE
5.3.1 Valneva SE Profile
5.3.2 Valneva SE Main Business
5.3.3 Valneva SE Cholera Vaccines Products, Services and Solutions
5.3.4 Valneva SE Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.3.5 Merck and Co., Inc. Recent Developments
5.4 Merck and Co., Inc.
5.4.1 Merck and Co., Inc. Profile
5.4.2 Merck and Co., Inc. Main Business
5.4.3 Merck and Co., Inc. Cholera Vaccines Products, Services and Solutions
5.4.4 Merck and Co., Inc. Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.4.5 Merck and Co., Inc. Recent Developments
5.5 GlaxoSmithKline plc (GSK)
5.5.1 GlaxoSmithKline plc (GSK) Profile
5.5.2 GlaxoSmithKline plc (GSK) Main Business
5.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Products, Services and Solutions
5.5.4 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline plc (GSK) Recent Developments
5.6 Astellas Pharma, Inc.
5.6.1 Astellas Pharma, Inc. Profile
5.6.2 Astellas Pharma, Inc. Main Business
5.6.3 Astellas Pharma, Inc. Cholera Vaccines Products, Services and Solutions
5.6.4 Astellas Pharma, Inc. Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.6.5 Astellas Pharma, Inc. Recent Developments
5.7 Pfizer, Inc.
5.7.1 Pfizer, Inc. Profile
5.7.2 Pfizer, Inc. Main Business
5.7.3 Pfizer, Inc. Cholera Vaccines Products, Services and Solutions
5.7.4 Pfizer, Inc. Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer, Inc. Recent Developments
5.8 Emergent BioSolutions, Inc.
5.8.1 Emergent BioSolutions, Inc. Profile
5.8.2 Emergent BioSolutions, Inc. Main Business
5.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Products, Services and Solutions
5.8.4 Emergent BioSolutions, Inc. Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.8.5 Emergent BioSolutions, Inc. Recent Developments
5.9 Mitsubishi Tanabe Pharma Corporation
5.9.1 Mitsubishi Tanabe Pharma Corporation Profile
5.9.2 Mitsubishi Tanabe Pharma Corporation Main Business
5.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Products, Services and Solutions
5.9.4 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.9.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
5.10 Takeda Pharmaceutical Co., Ltd.
5.10.1 Takeda Pharmaceutical Co., Ltd. Profile
5.10.2 Takeda Pharmaceutical Co., Ltd. Main Business
5.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Products, Services and Solutions
5.10.4 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (US$ Million) & (2018-2023)
5.10.5 Takeda Pharmaceutical Co., Ltd. Recent Developments
6 North America
6.1 North America Cholera Vaccines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cholera Vaccines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cholera Vaccines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cholera Vaccines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cholera Vaccines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cholera Vaccines Market Dynamics
11.1 Cholera Vaccines Industry Trends
11.2 Cholera Vaccines Market Drivers
11.3 Cholera Vaccines Market Challenges
11.4 Cholera Vaccines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
